Cargando…

Scaling Up the 2010 World Health Organization HIV Treatment Guidelines in Resource-Limited Settings: A Model-Based Analysis

BACKGROUND: The new 2010 World Health Organization (WHO) HIV treatment guidelines recommend earlier antiretroviral therapy (ART) initiation (CD4<350 cells/µl instead of CD4<200 cells/µl), multiple sequential ART regimens, and replacement of first-line stavudine with tenofovir. This paper consi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Walensky, Rochelle P., Wood, Robin, Ciaranello, Andrea L., Paltiel, A. David, Lorenzana, Sarah B., Anglaret, Xavier, Stoler, Adam W., Freedberg, Kenneth A.
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3014084/ https://www.ncbi.nlm.nih.gov/pubmed/21209794 http://dx.doi.org/10.1371/journal.pmed.1000382

Ejemplares similares

Cost-effectiveness of World Health Organization 2010 Guidelines for Prevention of Mother-to-Child HIV Transmission in Zimbabwe
por: Ciaranello, Andrea L., et al.
Publicado: (2013)

Early infant HIV-1 diagnosis programs in resource-limited settings: opportunities for improved outcomes and more cost-effective interventions
por: Ciaranello, Andrea L, et al.
Publicado: (2011)

The Survival Benefits of Antiretroviral Therapy in South Africa
por: April, Michael D., et al.
Publicado: (2014)

WHO 2010 Guidelines for Prevention of Mother-to-Child HIV Transmission in Zimbabwe: Modeling Clinical Outcomes in Infants and Mothers
por: Ciaranello, Andrea L., et al.
Publicado: (2011)

The Clinical and Economic Impact of Point-of-Care CD4 Testing in Mozambique and Other Resource-Limited Settings: A Cost-Effectiveness Analysis
por: Hyle, Emily P., et al.
Publicado: (2014)

Setting Performance Standards for a Cost-Effective Human Immunodeficiency Virus Cure Strategy in South Africa
por: Paltiel, A. David, et al.
Publicado: (2017)

Cost-Effectiveness of Preventing Loss to Follow-up in HIV Treatment Programs: A Côte d'Ivoire Appraisal
por: Losina, Elena, et al.
Publicado: (2009)

Cost-effectiveness and budget impact of immediate antiretroviral therapy initiation for treatment of HIV infection in Côte d’Ivoire: A model-based analysis
por: Ouattara, Eric N., et al.
Publicado: (2019)

Potential Clinical and Economic Value of Long-Acting Preexposure Prophylaxis for South African Women at High-Risk for HIV Infection
por: Walensky, Rochelle P., et al.
Publicado: (2016)

The cost‐effectiveness and budgetary impact of a dolutegravir‐based regimen as first‐line treatment of HIV infection in India
por: Zheng, Amy, et al.
Publicado: (2018)

HIV Testing After a First Positive Rapid Diagnostic Test: A Role for Nucleic Acid Testing?
por: Neilan, Anne M, et al.
Publicado: (2018)

Point-of-Care CD4 Testing to Inform Selection of Antiretroviral Medications in South African Antenatal Clinics: A Cost-Effectiveness Analysis
por: Ciaranello, Andrea L., et al.
Publicado: (2015)

Evaluating Point-of-Care Nucleic Acid Tests in Adult Human Immunodeficiency Virus Diagnostic Strategies: A Côte d’Ivoire Modeling Analysis
por: Neilan, Anne M, et al.
Publicado: (2021)

Assessment of SARS-CoV-2 Screening Strategies to Permit the Safe Reopening of College Campuses in the United States
por: Paltiel, A. David, et al.
Publicado: (2020)

COVID-19 screening strategies that permit the safe re-opening of college campuses
por: Paltiel, A. David, et al.
Publicado: (2020)

Estimating age-based antiretroviral therapy costs for HIV-infected children in resource-limited settings based on World Health Organization weight-based dosing recommendations
por: Doherty, Kathleen, et al.
Publicado: (2014)

Optimal breastfeeding durations for HIV‐exposed infants: the impact of maternal ART use, infant mortality and replacement feeding risk
por: Mallampati, Divya, et al.
Publicado: (2018)

Mobile HIV Screening in Cape Town, South Africa: Clinical Impact, Cost and Cost-Effectiveness
por: Bassett, Ingrid V., et al.
Publicado: (2014)

COVID-19 PICU guidelines: for high- and limited-resource settings
por: Kache, Saraswati, et al.
Publicado: (2020)

What Will It Take to Eliminate Pediatric HIV? Reaching WHO Target Rates of Mother-to-Child HIV Transmission in Zimbabwe: A Model-Based Analysis
por: Ciaranello, Andrea L., et al.
Publicado: (2012)

Challenges and Solutions in translating sepsis guidelines into practice in resource-limited settings
por: Ranjit, Suchitra, et al.
Publicado: (2021)

Linkage to HIV, TB and Non-Communicable Disease Care from a Mobile Testing Unit in Cape Town, South Africa
por: Govindasamy, Darshini, et al.
Publicado: (2013)

Antiretroviral Therapy for Control of the HIV-associated Tuberculosis Epidemic in Resource-Limited Settings
por: Lawn, Stephen D., et al.
Publicado: (2009)

Tuberculosis in Antiretroviral Treatment Services in Resource-Limited Settings: Addressing the Challenges of Screening and Diagnosis
por: Lawn, Stephen D., et al.
Publicado: (2011)

The value of confirmatory testing in early infant HIV diagnosis programmes in South Africa: A cost-effectiveness analysis
por: Dunning, Lorna, et al.
Publicado: (2017)

Resource Utilization and Cost-Effectiveness of Counselor- vs. Provider-Based Rapid Point-of-Care HIV Screening in the Emergency Department
por: Walensky, Rochelle P., et al.
Publicado: (2011)

Improving HIV outcomes in resource-limited countries: the importance of quality indicators
por: Ahonkhai, Aima A, et al.
Publicado: (2012)

Strengthening Existing Laboratory-Based Systems vs. Investing in Point-of-Care Assays for Early Infant Diagnosis of HIV: A Model-Based Cost-Effectiveness Analysis
por: McCann, Nicole C., et al.
Publicado: (2020)

Cost-effectiveness of integrating postpartum antiretroviral therapy and infant care into maternal & child health services in South Africa
por: Dugdale, Caitlin M., et al.
Publicado: (2019)

Cost-Effectiveness of HIV Testing Referral Strategies among Tuberculosis Patients in India
por: Uhler, Lauren M., et al.
Publicado: (2010)

Patient- and population-level health consequences of discontinuing antiretroviral therapy in settings with inadequate HIV treatment availability
por: Kimmel, April D, et al.
Publicado: (2012)

Management of HIV-associated tuberculosis in resource-limited settings: a state-of-the-art review
por: Lawn, Stephen D, et al.
Publicado: (2013)

Survival benefits of antiretroviral therapy in Brazil: a model-based analysis
por: Luz, Paula M, et al.
Publicado: (2016)

HIV Cure Strategies: How Good Must They Be to Improve on Current Antiretroviral Therapy?
por: Sax, Paul E., et al.
Publicado: (2014)

Developing prehospital clinical practice guidelines for resource limited settings: why re-invent the wheel?
por: McCaul, Michael, et al.
Publicado: (2018)

Cost-Effectiveness of Preemptive Switching to Efavirenz-Based Antiretroviral Therapy for Children With Human Immunodeficiency Virus
por: Desmonde, Sophie, et al.
Publicado: (2019)

965. Projecting the Potential Clinical and Economic Impact of HIV Prevention Resource Reallocation in Tennessee
por: Borre, Ethan D, et al.
Publicado: (2023)

Cost-Effectiveness of Genotype Testing for Primary Resistance in Brazil
por: Luz, Paula M., et al.
Publicado: (2015)

Cost-effectiveness of first-line antiretroviral therapy for HIV-infected African children less than 3 years of age
por: Ciaranello, Andrea L., et al.
Publicado: (2015)

The cost‐effectiveness of HIV pre‐exposure prophylaxis in men who have sex with men and transgender women at high risk of HIV infection in Brazil
por: Luz, Paula M, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_61nm9r71e849jjpkm5hbtc58f1